Immuron Ltd
IMRN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001660046
No open-market purchases or sales by Immuron Ltd insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $82.2K in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Immuron Ltd changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 7 | 6 | −1 |
| Shares | 95.3K | 92.8K | −2.51K (−2.6%) |
| Value | $198.2K | $171.5K | −$26.7K (−13.5%) |
New holders (1)
Institutions that held Immuron Ltd at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Old Mission Capital LLC | 15,537 | $29.1K | 0.00% |
Sold out (2)
Institutions that held Immuron Ltd at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Advisory Services Network, LLC | 500 | $1.04K |
| BNP Paribas Arbitrage, SA | 100 | $208 |